ReachMD

Episodes 1-3 of 3

• • 

    

    Anthony Mato, MD, MSCE

    Peer

  3

  

  RestartResume

  Non-Covalent BTK Inhibitors for B-Cell Malignancies (MCL/CLL): Setting the Stage for Future Use

  Non-Covalent BTK Inhibitors for B-Cell Malignancies (MCL/CLL): Setting the Stage for Future Use

  0.50 credits

• • 

    

    Fuad El Rassi, MD

    Peer

  4

  

  RestartResume

  Improving Interprofessional Management of Sickle Cell Disease With Disease-Directed Therapies

  Improving Interprofessional Management of Sickle Cell Disease With Disease-Directed Therapies

  0.50 credits

• • 

    

    Heather Wakelee, MD, FASCO

    Peer

  4

  

  RestartResume

  Adjuvant Treatment of Early Non–Small Cell Lung Cancer in the Era of Immunotherapy

  Adjuvant Treatment of Early Non–Small Cell Lung Cancer in the Era of Immunotherapy

  0.50 credits